相关实验视频
Updated: Jul 24, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
[对高风险和中高风险的肺血栓塞栓症进行血栓溶解疗法的研究进展]
概括
急性肺血栓塞栓症 (PTE) 治疗的重点是确定适合救命纤维解毒剂治疗的患者,并尽量减少出血风险. 最近的研究探讨了风险分层,出血评估和血栓溶解的有效性,以改善患者的治疗结果和预防PE后综合征.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 关键的护理关键的护理
背景情况:
- 急性肺血栓塞栓症 (PTE) 是死亡的一个重要原因.
- 纤维溶解疗法提供了快速的血液动力学改善,对于拯救生命的干预至关重要.
- 优化对血栓溶解的患者选择和减轻主要出血并发症仍然是PTE管理的关键挑战.
研究的目的:
- 审查肺血栓塞栓症治疗的最新进展.
- 评估对风险分层,出血评估和治疗干预措施的不断变化的理解.
- 评估血栓消毒疗法在预防PE后综合征 (PPES) 中的潜在益处.
主要方法:
- 综述最近关于PTE早期风险分层和预后的研究.
- 对评估与血栓溶解相关的主要出血风险的研究进行分析.
- 对降低血栓溶解药物剂量和干预性血栓溶解技术的研究进行审查.
- 对PTE进行血栓溶解治疗后的长期预后数据的评估.
主要成果:
- 在PTE患者的早期风险分层和预后评估方面取得了进展.
- 正在完善降低血栓治疗期间主要出血并发症的策略.
- 新出现的证据表明,血栓溶解药物治疗在缓解PE后综合征方面具有潜在的益处.
结论:
- 持续的研究对于完善PTE风险分层和出血评估至关重要.
- 血栓缓解药物治疗,当适当地应用时,可以显著改善急性PTE的结果.
- 需要进一步研究血栓溶解后的长期预后和PPES预防.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
13
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
13
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Pulmonary Embolism III: Nursing Management
15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Pulmonary Embolism I: Introduction
9
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
9
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
218
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
218

